Clinical Trails & Bio therapeutics

Clinical Bio therapeutic aspects including study drug formulations, drug design, drug-drug interactions, QT assessment, immunogenicity, comparability, special populations (hepatic and liver failure), PK and PD, regulatory expectations of PK and PD characterization, as well as reviewing factors which influence the ADME of Bio therapeutics. The objectives of early clinical development of therapeutic proteins are the same as for small molecules i.e. to investigate the molecule in a manner that will gain necessary knowledge about its tolerability safety pharmacokinetics (PK) and if possible pharmacodynamics (PD) effects in the most appropriate human populations while simultaneously protecting their safety. However, there are specific features of proteins that must be considered when designing clinical pharmacology studies.

 

  • Discovery & Preclinical Testing
  • Clinical Study Designs
  • Data Collection & Quality Control
  • Advanced Information Technology in Clinical trials
  • Clinical Trial Protocol

Related Conference of Clinical Trails & Bio therapeutics

December 10-11, 2020

21st World Summit on Nanotechnology and Expo

Osaka, Japan
February 10-11, 2021

32nd European Congress on Nanotechnology and Materials Engineering

Amsterdam, Netherlands
February 26-26, 2021

24th World Nanotechnology Congress

Abu Dhabi, UAE
April 28-29, 2021

33rd Nano Congress for Future Advancements

London, UK
May 21-22, 2021

18th Nanotechnology and Nano Medicine

Osaka, Japan
June 09-10, 2021

6th Annual Conference and Expo on Biomaterials

Berlin, Germany
August 03-04, 2021

4th World Congress on Nanoscience and Nano Technology

Hanoi, Vietnam
August 10-11, 2021

5th Annual Congress on Nanomedicine and Drug Delivery

Bangkok, Thailand
November 15-16, 2021

34th International Conference on Nanotechnology & Expo

Madrid, Spain

Clinical Trails & Bio therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in